Edition:
United Kingdom

Akebia Therapeutics Inc (AKBA.OQ)

AKBA.OQ on NASDAQ Stock Exchange Global Market

15.23USD
23 Feb 2018
Change (% chg)

$0.20 (+1.33%)
Prev Close
$15.03
Open
$15.08
Day's High
$15.26
Day's Low
$14.78
Volume
110,974
Avg. Vol
129,510
52-wk High
$20.25
52-wk Low
$8.60

Select another date:

Mon, Feb 12 2018

BRIEF-Akebia Therapeutics Gives Update On Vadadustat Development Program

* AKEBIA THERAPEUTICS PROVIDES UPDATE ON VADADUSTAT DEVELOPMENT PROGRAM

BRIEF-Akebia Therapeutics reports Q3 loss per share $0.49

* Akebia Therapeutics announces third quarter 2017 financial results

BRIEF-Invirsa secures seed financing to develop new approach

* Invirsa secures seed financing to develop new approach to treating common infectious diseases that affect millions annually Source text for Eikon: Further company coverage:

Insider trading suspect out of U.S. jail as judge weighs 'Jekyll & Hyde' risk

BOSTON, Oct 12 A former Akebia Therapeutics Inc employee accused of insider trading was released from jail on Thursday despite a judge's concern that the man's "Dr. Jekyll and Mr. Hyde" tendencies could lead him to violate his bail conditions.

Ex-Akebia employee suspected of insider trading re-arrested

BOSTON A former Akebia Therapeutics Inc employee accused of insider trading was re-arrested on Friday after violating a bail condition as a prosecutor who once called him "increasingly unhinged" said he would seek the man's detention pending trial.

Ex-Akebia employee suspected of insider trading re-arrested

BOSTON, Sept 22 A former Akebia Therapeutics Inc employee accused of insider trading was re-arrested on Friday after violating a bail condition as a prosecutor who once called him "increasingly unhinged" said he would seek the man's detention pending trial.

Select another date: